Scholarlink

Purpose of Review <p>Achalasia is a chronic esophageal motility disorder for which available therapies are palliative rather than curative. Although lower esophageal sphincter-directed interventions provide excellent short-term relief, recurrence and late complications are common. This review aims to synthesize current evidence on mechanisms of recurrent or persistent symptoms after achalasia treatment, outline a pragmatic framework for longitudinal monitoring, and summarize management strategies for recurrent and advanced disease.</p> Recent Findings <p>Recent studies emphasize the limitations of symptom-based follow-up and highlight the need for longitudinal follow-up with the utilization of complementary physiologic and anatomic assessment. Timed barium esophagram, endoscopy, high-resolution manometry, and EndoFLIP provide distinct but interrelated insights into esophagogastric junction function, esophageal emptying, and structural remodeling. Current emerging data underscores the role of anatomy-driven bolus retention, including pseudodiverticula, sigmoid deformity, and sump configurations, in late treatment failure, even when esophagogastric junction opening appears adequate. Comparative data on re-intervention demonstrate that pneumatic dilation, redo myotomy, and peroral endoscopic myotomy can be effective when appropriately matched to the primary failure mechanism.</p> Summary <p>Achalasia requires lifelong surveillance and individualized management approaches. Effective longitudinal care depends on mechanism-based evaluation that distinguishes recurrent outflow obstruction from anatomy-driven retention and functional overlap syndromes. Integrating objective anatomical and physiological diagnostic tools with clinical context clarifies the underlying etiology and allows for more rational selection of re-intervention. Future research should focus on refining surveillance strategies, validating approaches to etiology-based re-intervention, and further investigating emerging esophagus-preserving therapies for advanced disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Longitudinal Management of Achalasia: Monitoring and Management of Recurrence and Complications

  • 期刊论文

  • 发表日期：

    2026年3月17日

查看全文
  • Shree Patel,
  • Anand Jain

摘要

Purpose of Review

Achalasia is a chronic esophageal motility disorder for which available therapies are palliative rather than curative. Although lower esophageal sphincter-directed interventions provide excellent short-term relief, recurrence and late complications are common. This review aims to synthesize current evidence on mechanisms of recurrent or persistent symptoms after achalasia treatment, outline a pragmatic framework for longitudinal monitoring, and summarize management strategies for recurrent and advanced disease.

Recent Findings

Recent studies emphasize the limitations of symptom-based follow-up and highlight the need for longitudinal follow-up with the utilization of complementary physiologic and anatomic assessment. Timed barium esophagram, endoscopy, high-resolution manometry, and EndoFLIP provide distinct but interrelated insights into esophagogastric junction function, esophageal emptying, and structural remodeling. Current emerging data underscores the role of anatomy-driven bolus retention, including pseudodiverticula, sigmoid deformity, and sump configurations, in late treatment failure, even when esophagogastric junction opening appears adequate. Comparative data on re-intervention demonstrate that pneumatic dilation, redo myotomy, and peroral endoscopic myotomy can be effective when appropriately matched to the primary failure mechanism.

Summary

Achalasia requires lifelong surveillance and individualized management approaches. Effective longitudinal care depends on mechanism-based evaluation that distinguishes recurrent outflow obstruction from anatomy-driven retention and functional overlap syndromes. Integrating objective anatomical and physiological diagnostic tools with clinical context clarifies the underlying etiology and allows for more rational selection of re-intervention. Future research should focus on refining surveillance strategies, validating approaches to etiology-based re-intervention, and further investigating emerging esophagus-preserving therapies for advanced disease.